{"entity":{"type":"insider","cik":"0001760020","url":"/insider/0001760020","json_url":"/insider/0001760020.json","name":"HEGGIE THERESA","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2019-11-18","last":"2026-03-24","span_basis":"filed_date"},"name_variants":[{"name":"HEGGIE THERESA","source":"filing","n_filings":4,"first_seen":"2019-11-18","last_seen":"2026-03-24"}],"transactions":[{"id":6216319,"accession":"0000882796-26-000017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000882796-26-000017","line_url":"/filing/0000882796-26-000017#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001760020","owner_name":"HEGGIE THERESA","owner_display_name":"HEGGIE THERESA","owner_url":"/insider/0001760020","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49933.0,"shares_display":"49,933","price_per_share":10.11,"price_display":"10.11","price_state":"stated","total_value":504822.63,"total_display":"504,822.63","total_whole":"504,823","shares_owned_after":65352.0,"shares_owned_after_display":"65,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-20","filed_date":"2026-03-24","scope":"insider"},{"id":4350409,"accession":"0001127602-25-020491","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-25-020491","line_url":"/filing/0001127602-25-020491#line-3","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001760020","owner_name":"HEGGIE THERESA","owner_display_name":"HEGGIE THERESA","owner_url":"/insider/0001760020","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70000.0,"shares_display":"70,000","price_per_share":8.5124,"price_display":"8.51","price_state":"stated","total_value":595868.0,"total_display":"595,868.00","total_whole":"595,868","shares_owned_after":65352.0,"shares_owned_after_display":"65,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-13","filed_date":"2025-08-15","scope":"insider"},{"id":2036046,"accession":"0001127602-24-018715","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-018715","line_url":"/filing/0001127602-24-018715#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001760020","owner_name":"HEGGIE THERESA","owner_display_name":"HEGGIE THERESA","owner_url":"/insider/0001760020","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6698.0,"shares_display":"6,698","price_per_share":6.11,"price_display":"6.11","price_state":"stated","total_value":40924.78,"total_display":"40,924.78","total_whole":"40,925","shares_owned_after":52852.0,"shares_owned_after_display":"52,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-14","filed_date":"2024-06-14","scope":"insider"},{"id":8641270,"accession":"0001127602-19-033017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-19-033017","line_url":"/filing/0001127602-19-033017#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001760020","owner_name":"HEGGIE THERESA","owner_display_name":"HEGGIE THERESA","owner_url":"/insider/0001760020","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":7250.0,"total_display":"7,250.00","total_whole":"7,250","shares_owned_after":6672.0,"shares_owned_after_display":"6,672","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000882796","name":"BIOCRYST PHARMACEUTICALS INC","url":"/issuer/0000882796","role":"Director","n_filings":4,"first_seen":"2019-11-18","last_seen":"2026-03-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001760020","retrieved_at":"2026-08-22T17:01:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}